Skip to main content
Equibles

MORGAN STANLEY

Position in CRMD — CorMedix Inc.

CIK 895421 NEW YORK, NY
Back to CRMD Full portfolio

Position in CRMD

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,323,224
+$365,239 QoQ
Shares Held
423,341
-2.8% QoQ
Ownership
0.543%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 194 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 66% Shared 0% None 34%

Common Shares in CRMD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. CRMD ranks #184 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in CRMD

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,323,224 423,341
2026-03-31 $2,957,985 435,639
2025-12-31 $7,545,099 648,762
2025-09-30 $9,810,726 843,571
2025-06-30 $9,452,555 767,253
2025-03-31 $4,335,035 703,740
2024-12-31 $3,230,674 398,849
2024-09-30 $2,766,475 342,386
2024-06-30 $1,175,431 271,463
2024-03-31 $830,836 195,953
2023-12-31 $943,657 250,973
2023-09-30 $487,291 131,701
2023-06-30 $760,066 191,453
2022-12-31 $520,256 123,284
2022-09-30 $353,162 124,793
2022-06-30 $1,072,863 266,882
2022-03-31 $1,204,781 219,851
2021-12-31 $693,513 152,421
2021-09-30 $1,709,746 367,688
2021-06-30 $2,082,866 303,625
2021-03-31 $2,829,676 283,251
2020-12-31 $288,335 38,807
2020-09-30 $243,490 40,380
2020-06-30 $70,131 11,132
2020-03-31 $58,225 16,219